Products 391209-97-5

CAS 391209-97-5 is the registry number for Pd 0325901, 95%. Offered by: Combi-blocks. Available pack sizes: 1g, 250mg.

Pd 0325901, 95%
Combi-blocks
  • size: 1g, 250mg
  • Variants: 2
View product
Structural formula: {0} (CAS {1})

PD 0325901 is a hydroxamic acid ester that is benzhydroxamic acid (N-hydroxybenzamide) in which the hydroxamic acid group has been converted to the corresponding 2,3-dihydroxypropyl ester and in which the benzene ring has been substituted at position 2 by a (2-fluoro-4-iodophenyl)amino group and at positions 3 and 4 by fluorines (the R enantiomer). It has a role as an antineoplastic agent and an EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor. It is a member of propane-1,2-diols, an organoiodine compound, a difluorobenzene, a secondary amino compound, a hydroxamic acid ester and a member of monofluorobenzenes.

Source: ChEBI

Identity
Molecular formulaC16H14F3IN2O4
Molecular weight482.19 g/mol
IUPAC nameN-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide
InChIKeySUDAHWBOROXANE-SECBINFHSA-N
SMILESC1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOC[C@@H](CO)O

Computed by PubChem (NCBI)

Synonyms: Mirdametinib, GOMEKLI, Pd 901, MEK Inhibitor PD0325901, Mirdametinib [USAN], MIRDAMETINIB [INN], N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide, Mirdametinib (USAN), Ezmekly, Ezmekly (TN)
Related forms of this compound
N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide C16H14F3IN2O4